Member Info for Openthebox

Positive interview - future looks bright but many LTH underwater, hope to see the momentum and news flow continue.

All seems very quiet here - sp has gone a bit flat compared to recent months prior and no new commentary on here for nearly 3 months! Leading payments focussed fintech.. Has / is this one slipping under the radar?

@molarcanine - sorry for your loss - your post, albeit sad in some respects, made me smile at the journey it has taken you on. He would love that you are both learning and continuing his journey and making it your own.

Have watched GGP from sidelines for several years and finally took the plunge in yesterday - thank you to many who post on here with useful insight and information.

ATB

Goingtothemoon is the biggest mug on here - pops up with pure uninformed secretive hype posts then disappears again.

Think that well and truly arrived yesterday…

Pippins am I missing something but didn’t see anything in that article relating to either celadon or jungle boys?

It can’t

Where’s the chap gone who was so bullish about this dog? Was it Chester something?

Investor comm’s rubbish after multiple attempts to contact directly, can't answer questions relating to IP or commercial licensing (not even a we can’t answer this).

Glad I swerved this POS.

It’s a public forum, this company and industry interest me. It’s not a pre-requisite that one must be invested to post here. Filter me if you don’t like it - otherwise jog on.

Swerved investing here for that reason alone, I had them on the phone asking questions and over also email and have had zero back on all fronts.

There are no offers on the table, this is just the usual and standard level of vague communications by the BOD. Maybe's, potentially's, likely's etc etc.

Sorry but just simply is not true. Some of the largest medical cannabis providers globally originated in USA, where the market has had literally 15-20 years head start, the most popular one operating in the UK is a company called Curaleaf - which believe it or not is American.

To suggest involved businesses and organisations in USA are just weed farmers is laughable.

Celadon, who don’t even make their own genetics, have arrived 15 + years later and apparently no one is doing it like them. Pull the other one please.

If you want to believe what has been written for surface value then sure.. But as someone previously mentioned, loss of confidence in BOD’s words and actions at all time low.

Hi Simon,

Must say I raised an eyebrow when reading that also - again, minimal information provided, but at what benefit would a USA based company have importing from uk when it has a ripe domestic market with bargain bucket prices (due to the over supply you mentioned).

Hi Elliot,

All sounds very positive and promising - I can share the feeling behind walking into a place such as this - truly very very impressive technology. I know you said signed an NDA so not expecting any sensitive info, but could you elaborate at all on the plant stress techniques you mentioned? As far as I am aware, these are just growing techniques to improve yield and do not have anything to do with genetics or breeding.

Thanks!

@Elliot

No need to apologise, it's good to have different opinions and perspectives on things - guess that's the beauty of it.

Maybe you are right, maybe not - I am just an enthusiast in this space and have a better knowledge and understanding of the plant / genetic side of things compared to most, especially when viewing it from an investment perspective - most here would have more focus on finances and results etc.

That said, in the USA (market much more advanced), it is possible to patent strains if they have unique features - for example, unusually high levels of myrcene or limonene - as this could have medical benefits. The requirements are strict to meet, but it's there to protect commercial interests.

In a commercial venture, I just cannot see there being no implications by NOT breeding your own genetics. As I say, I very well could be completely wrong, but I do not understand the company's approach to this. To give an example - lets say growing medicinal cannabis in the UK wasn't such a ring-fenced industry it currently is - many companies could grow the exact same strain / genetics, purchased freely on the open market. What do you think is going to happen to the price of Celadon's flower product? It'll collapse in price because there is an excess supply of the same product on the market.

Do the breeding work in-house, keep your genetics tightly owned, even patented in markets which will allow, and no other business entity can produce YOUR product without licensing agreements etc.

The website says "meticulously bred" etc - so why have they not spoken ANYTHING on the subject in any company documents. Surely as a business, you would be getting that information out there, highlighting the work done and the developments made on this "meticulous breeding" - there is none.

Just my small take on that particular angle of the company.

Will take months at least to understand the efficacy of treatment - the real milestone will be if these patients are still cancer free at 1/3/5 years.

Negative reactions like what?

Neurotoxicity is more likely to occur dependant on the severity of the cancer growth - but we are talking an end stage treatment here so likely the cancer is significant - odds on neurotoxicity will be present, as also likely that encephalitis could be also, or rarer chances of cerebral edema.

These are all par for the course risks, beyond these what are we looking for safety wise?

You will not find the outcome of a patient injected with CAR-T for a while. Its efficacy is not measured by its immediate impacts.

Injecting a patient with the CAR-T, while positive a sign of progress - is not a moment for celebration, and likely will not do much for the SP in the immediate term.

Their website says it’s meticulously bred from these genetics.

I would love some understanding of meticulously bred - because other than growing 100/500 plants out and choosing the preferred phenotypes out of those examples grown, which is just a pheno run, there really isn’t any “breeding” at play here.

Would love to be proved wrong and understand the work they have done to advance this, but the complete lack of information on this makes me believe they haven’t.